Pancreatitis Treatment in Dallas, TX

Medically reviewed by Jaison John, MD — Board-Certified Gastroenterologist
Last updated: March 2026

What Is Pancreatitis?

Pancreatitis is inflammation of the pancreas, a large gland located behind the stomach that plays a dual role in digestion and blood sugar regulation. The pancreas produces digestive enzymes (exocrine function) that are released into the small intestine to break down fats, proteins, and carbohydrates, and it produces hormones such as insulin and glucagon (endocrine function) that regulate blood glucose levels. Pancreatitis occurs when digestive enzymes become prematurely activated inside the pancreas, causing the organ to essentially begin digesting itself, leading to inflammation, swelling, and tissue damage.

Pancreatitis is a significant and growing public health concern in the United States. According to the American College of Gastroenterology (ACG), acute pancreatitis is one of the most common gastrointestinal reasons for hospitalization, accounting for more than 275,000 hospital admissions annually. The incidence of acute pancreatitis has been rising steadily over the past two decades, a trend attributed in part to increasing rates of obesity, gallstone disease, and alcohol use. Chronic pancreatitis, while less common, affects approximately 50 per 100,000 adults and is a leading cause of disability and reduced quality of life among patients with digestive diseases.

At Texas Gut Health in Sachse, TX, Dr. Jaison John provides expert evaluation and management of both acute and chronic pancreatitis for patients throughout the Dallas-Fort Worth area. Dr. John completed his gastroenterology fellowship at UT Medical Branch, where he served as Chief Fellow, and his internal medicine residency at UT Austin Dell Medical School, where he served as Chief Resident. He holds dual board certifications from the American Board of Internal Medicine in both internal medicine and gastroenterology. His advanced training in ERCP is particularly relevant for managing gallstone pancreatitis and pancreatic duct complications.

Acute vs. Chronic Pancreatitis

Pancreatitis is broadly classified into two forms, each with distinct clinical features, causes, and management strategies.

Acute Pancreatitis

Acute pancreatitis is a sudden onset of pancreatic inflammation that develops over hours to days. The severity ranges from mild (interstitial edematous pancreatitis), which accounts for approximately 80% of cases and typically resolves within one to two weeks with supportive care, to severe (necrotizing pancreatitis), which involves tissue death and can lead to organ failure, prolonged hospitalization, and significant morbidity and mortality. The revised Atlanta classification, widely used in clinical practice, categorizes acute pancreatitis as mild (no organ failure, no local or systemic complications), moderately severe (transient organ failure lasting less than 48 hours and/or local complications), or severe (persistent organ failure lasting more than 48 hours).

Chronic Pancreatitis

Chronic pancreatitis is a progressive, irreversible inflammatory condition characterized by ongoing destruction and fibrosis of the pancreatic tissue. Over time, the normal pancreatic architecture is replaced by scar tissue, leading to permanent loss of both exocrine and endocrine function. Chronic pancreatitis develops through two main pathways: recurrent episodes of acute pancreatitis that gradually cause cumulative damage (the "necrosis-fibrosis" pathway), or a more insidious, slowly progressive inflammatory process. The hallmark of chronic pancreatitis is chronic abdominal pain, which is often debilitating and difficult to manage. Late-stage chronic pancreatitis is characterized by exocrine pancreatic insufficiency (EPI), resulting in maldigestion, steatorrhea (fatty stools), and nutritional deficiencies, and by endocrine insufficiency, resulting in diabetes mellitus (known as type 3c diabetes).

Symptoms of Pancreatitis

The symptoms of pancreatitis vary depending on whether the condition is acute or chronic and on the severity of inflammation.

Symptoms of Acute Pancreatitis

• Severe upper abdominal pain — The hallmark symptom of acute pancreatitis is sudden, severe pain in the upper abdomen (epigastrium) that may radiate straight through to the back. The pain typically reaches maximum intensity within 30 minutes and is steady (not crampy). Many patients describe it as the worst abdominal pain they have ever experienced.
• Pain worsened by eating — Eating, particularly fatty foods, often intensifies the pain because it stimulates the release of digestive enzymes from the inflamed pancreas.
• Pain improved by leaning forward — Many patients find partial relief by leaning forward or curling into a fetal position, which reduces pressure on the pancreas.
• Nausea and vomiting — Nausea and vomiting are nearly universal in acute pancreatitis and may be severe enough to cause dehydration.
• Abdominal tenderness and distention — The abdomen may be tender to the touch and distended due to ileus (temporary cessation of bowel motility).
• Fever and rapid heart rate — Fever and tachycardia reflect the systemic inflammatory response and may indicate developing complications.

Symptoms of Chronic Pancreatitis

• Chronic, recurrent abdominal pain — Pain in chronic pancreatitis is typically epigastric, radiates to the back, and may be constant or episodic. Pain episodes can last hours to days and may be triggered by eating or alcohol consumption. Over time, some patients experience "painless" chronic pancreatitis as the pancreatic nerves become destroyed (so-called "burnout"), though this is not universal.
• Steatorrhea (fatty, oily stools) — When chronic pancreatitis destroys enough of the exocrine pancreas (typically more than 90% of function must be lost), the body can no longer produce sufficient digestive enzymes to break down dietary fat. This results in loose, greasy, foul-smelling stools that float and are difficult to flush.
• Unintentional weight loss — Maldigestion and reduced caloric intake due to pain-associated eating avoidance lead to progressive weight loss and malnutrition.
• Diabetes mellitus — Destruction of the insulin-producing islet cells in the pancreas can lead to type 3c (pancreatogenic) diabetes, which may require insulin therapy.
• Nutritional deficiencies — Impaired absorption of fat-soluble vitamins (A, D, E, K) and other nutrients can lead to bone loss, easy bruising, night vision problems, and other deficiency-related symptoms.

Causes & Risk Factors

The causes of pancreatitis differ between acute and chronic forms, though there is significant overlap. Identifying the underlying cause is essential for guiding treatment and preventing recurrence.

Causes of Acute Pancreatitis

• Gallstones (gallstone pancreatitis) — Gallstones are the most common cause of acute pancreatitis, accounting for approximately 40% of cases. Gallstone pancreatitis occurs when a stone migrates from the gallbladder and temporarily obstructs the ampulla of Vater, the shared opening where the bile duct and pancreatic duct empty into the duodenum. This obstruction causes pancreatic enzymes to back up and become activated within the pancreas. ERCP may be needed urgently to remove an impacted stone, and cholecystectomy (gallbladder removal) after recovery prevents recurrence.
• Alcohol use — Alcohol is the second most common cause of acute pancreatitis (approximately 25% to 35% of cases) and the leading cause of chronic pancreatitis. The exact mechanism is not fully understood, but alcohol is thought to cause premature activation of digestive enzymes within the pancreas, increase the viscosity of pancreatic secretions, and promote formation of protein plugs that obstruct small pancreatic ducts. Sustained heavy alcohol use (typically more than 4 to 5 drinks per day over many years) is the major risk factor, though some individuals develop pancreatitis at lower levels of consumption.
• Hypertriglyceridemia — Very high blood triglyceride levels (typically above 1,000 mg/dL) are the third most common cause of acute pancreatitis, responsible for approximately 1% to 4% of cases. Triglyceride-induced pancreatitis is thought to result from the toxic effects of free fatty acids released from triglyceride hydrolysis within pancreatic capillaries.
• Post-ERCP pancreatitis — Pancreatitis is the most common complication of ERCP, occurring in approximately 3% to 10% of procedures. Risk factors include younger age, female sex, normal bilirubin, and difficult cannulation. Preventive measures such as rectal indomethacin and prophylactic pancreatic duct stent placement have significantly reduced this risk.
• Medications — Numerous medications have been associated with drug-induced pancreatitis, including certain immunosuppressants (azathioprine, 6-mercaptopurine), anti-seizure medications (valproic acid), GLP-1 receptor agonists, certain antibiotics, and some diuretics.
• Other causes — Less common causes include autoimmune pancreatitis (types 1 and 2), pancreatic divisum (a congenital anatomical variant), trauma, infections (mumps, coxsackie virus), hypercalcemia, and genetic mutations (PRSS1, SPINK1, CFTR). In 15% to 25% of cases, no cause is identified despite thorough evaluation (idiopathic pancreatitis).

Causes of Chronic Pancreatitis

• Alcohol — Chronic, heavy alcohol use is the most common cause of chronic pancreatitis, responsible for approximately 40% to 70% of cases. The risk is dose-dependent, with heavy drinkers (more than 5 drinks per day) having the highest risk.
• Smoking — Cigarette smoking is an independent and significant risk factor for chronic pancreatitis. Smoking accelerates the progression of alcohol-related pancreatitis and is associated with chronic pancreatitis even in the absence of alcohol use.
• Genetic factors — Hereditary pancreatitis (PRSS1 mutations) and other genetic variants (SPINK1, CFTR, CTRC) can predispose individuals to recurrent acute pancreatitis and progression to chronic pancreatitis, often at a young age.
• Obstruction — Physical obstruction of the pancreatic duct by tumors, strictures, or stones can lead to upstream inflammation and chronic damage.
• Autoimmune pancreatitis — Autoimmune pancreatitis is a distinct form of chronic pancreatitis driven by the immune system. Type 1 (IgG4-related) autoimmune pancreatitis is a systemic disease, while Type 2 is limited to the pancreas. Both forms typically respond to corticosteroid therapy.
• Recurrent acute pancreatitis — Repeated episodes of acute pancreatitis, regardless of cause, can lead to progressive fibrosis and the development of chronic pancreatitis over time.

How Pancreatitis Is Diagnosed

The diagnosis of acute pancreatitis requires meeting at least two of three criteria established by the revised Atlanta classification: (1) characteristic abdominal pain, (2) serum lipase or amylase elevated to at least three times the upper limit of normal, and (3) characteristic findings on imaging. Most cases can be diagnosed on the basis of clinical presentation and blood tests alone.

Blood Tests

Serum lipase is the preferred blood test for diagnosing acute pancreatitis. Lipase is more sensitive and specific for pancreatitis than amylase and remains elevated for a longer period (up to 14 days versus 3 to 5 days for amylase). A lipase level three or more times the upper limit of normal is highly suggestive of acute pancreatitis. Additional blood tests are used to assess severity (complete blood count, comprehensive metabolic panel, C-reactive protein, lactate) and to identify the cause (liver function tests and bilirubin for gallstone pancreatitis, triglyceride levels, calcium levels).

Imaging

Imaging is not required to diagnose acute pancreatitis when clinical and laboratory criteria are met, but it plays a critical role in assessing severity, detecting complications, and identifying the underlying cause.

• CT scan with contrast — Contrast-enhanced CT is the imaging modality of choice for evaluating the severity of acute pancreatitis, particularly for identifying pancreatic necrosis, fluid collections, pseudocysts, and other complications. The ACG recommends CT imaging when the diagnosis is uncertain, when the patient does not improve within 48 to 72 hours, or when complications are suspected.
• Abdominal ultrasound — Ultrasound is recommended in all patients with a first episode of acute pancreatitis to evaluate for gallstones as the underlying cause. It is also the initial imaging test for evaluating bile duct dilation.
• MRCP — Magnetic resonance cholangiopancreatography provides detailed, non-invasive imaging of the bile ducts and pancreatic duct. It is used to detect bile duct stones, pancreatic duct strictures, anatomical variants (such as pancreas divisum), and chronic pancreatitis changes.
• Endoscopic ultrasound (EUS) — EUS offers the highest-resolution imaging of the pancreas and is valuable for detecting microlithiasis (tiny gallstones), early chronic pancreatitis changes, and pancreatic masses. It can also be used to sample fluid collections and guide drainage procedures.

Diagnosing Chronic Pancreatitis

Chronic pancreatitis can be more challenging to diagnose, particularly in its early stages. Diagnosis is based on a combination of clinical presentation (chronic abdominal pain, steatorrhea, weight loss, diabetes), imaging findings (pancreatic calcifications, duct dilation, duct stones, parenchymal atrophy), and functional testing (fecal elastase-1 to assess exocrine function). EUS with detailed evaluation using the Rosemont criteria is considered the most sensitive imaging test for detecting early chronic pancreatitis.

Treatment Options

Treatment for pancreatitis depends on whether the condition is acute or chronic, the underlying cause, and the severity of the disease.

Treatment of Acute Pancreatitis

The management of acute pancreatitis focuses on supportive care, pain control, and addressing the underlying cause. Key elements include:

• Aggressive IV fluid resuscitation — Early, aggressive intravenous fluid administration (typically lactated Ringer's solution) is a cornerstone of acute pancreatitis management. Adequate hydration helps maintain pancreatic perfusion, prevent organ failure, and reduce the risk of necrosis. The ACG recommends goal-directed fluid therapy, with careful monitoring to avoid both under-resuscitation and fluid overload.
• Pain management — Pain control is a priority. Multimodal analgesia, including opioids when necessary, non-opioid analgesics, and adjunctive therapies, is used to manage the often-severe pain of acute pancreatitis. Patient-controlled analgesia (PCA) may be used for severe pain.
• Early oral feeding — Current guidelines recommend initiating oral feeding as soon as the patient can tolerate it, rather than waiting for complete resolution of pain or normalization of enzyme levels. Low-fat solid foods can typically be started within 24 hours in mild acute pancreatitis. This approach has been shown to reduce hospital length of stay and complications.
• ERCP for gallstone pancreatitis — The ACG recommends urgent ERCP (within 24 hours) for patients with gallstone pancreatitis complicated by concurrent cholangitis. Early ERCP is also recommended for patients with persistent biliary obstruction (elevated bilirubin that does not improve). Following recovery from gallstone pancreatitis, cholecystectomy should be performed during the same hospitalization (for mild cases) or within 2 to 4 weeks to prevent recurrence.
• Management of complications — Severe acute pancreatitis may require ICU-level care for organ failure, interventional drainage of infected necrotic collections (step-up approach), and nutritional support via nasojejunal feeding or parenteral nutrition when oral intake is not possible.

Treatment of Chronic Pancreatitis

• Pain management — Chronic pain is the most challenging aspect of chronic pancreatitis management. A stepwise approach includes lifestyle modifications (alcohol cessation, smoking cessation), non-opioid analgesics (acetaminophen, NSAIDs, gabapentinoids), pancreatic enzyme replacement therapy (which may reduce pain by providing feedback inhibition of pancreatic secretion), and referral to a pain management specialist when needed. Endoscopic therapies and surgery may be considered for selected patients with ductal obstruction.
• Pancreatic enzyme replacement therapy (PERT) — For patients with exocrine pancreatic insufficiency (confirmed by symptoms of maldigestion and low fecal elastase-1 levels), PERT is the mainstay of treatment. Prescription pancreatic enzyme capsules (containing lipase, protease, and amylase) are taken with meals and snacks to replace the enzymes the damaged pancreas can no longer produce in adequate quantities. The dose is titrated based on symptom response, with the typical initial dose being 40,000 to 50,000 lipase units per meal.
• Nutritional support — Patients with chronic pancreatitis are at high risk for malnutrition. Dietary counseling, fat-soluble vitamin supplementation (A, D, E, K), and optimization of caloric intake are essential components of care. Small, frequent meals with moderate fat content are generally recommended.
• Diabetes management — Type 3c diabetes resulting from chronic pancreatitis requires careful management, often with insulin therapy. These patients are at increased risk for hypoglycemia because they also lose glucagon production.
• Endoscopic and surgical therapies — ERCP may be used to remove pancreatic duct stones, dilate pancreatic duct strictures, or place stents to improve drainage. In selected patients with refractory pain and favorable anatomy, surgical options such as lateral pancreaticojejunostomy (Puestow procedure) or total pancreatectomy with islet autotransplantation (TPIAT) may be considered.
• Alcohol and smoking cessation — Abstinence from alcohol and cessation of smoking are the most important modifiable factors in slowing the progression of chronic pancreatitis and reducing the risk of complications, including pancreatic cancer.

Frequently Asked Questions